Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening

Journal of Medical Genetics

Volumn 44, Issue 8, 2007, Pages 481-484

  Sharif, S ^b   Moran, A ^c   Huson, S M ^a   Iddenden, R ^c   Shenton, A ^a   Howard, E ^a   Evans, D G R ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^c North West Cancer Intelligence Service ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NEUROFIBROMATOSIS; POPULATION RESEARCH; PRIORITY JOURNAL; WOMEN'S HEALTH;

AGE OF ONSET; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENETIC SCREENING; HUMANS; INCIDENCE; MAMMOGRAPHY; NEUROFIBROMATOSIS 1; ONTARIO; RISK;

EID: 34447562827     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2007.049346     Document Type: Article

References (32)

1. Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 1988;111(Pt 6):1355.
2. Riccardi. Neurofibromatosis: phenotype, natural history and pathogenesis. Baltimore: Johns Hopkins University Press, 1992.
3. Airewele GE, Sigurdson AJ, Wiley KJ, Frieden BE, Caldarera LW, Riccardi VM, Lewis RA, Chintagumpala MM, Ater JL, Plon SE, Bondy ML. Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer. Genet Epidemiol 2001;20:75.
4. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 1986;314:1010.
5. Zoller ME, Rembeck B, Oden A, Samuelsson M, Angervall L. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 1997;79:2125.
6. Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I, Baralle D. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer 2006;95:233-8.
7. McIntosh A SC, Evans G, Turnbull N, Bahar N, Barclay M, Easton D, Emery J, Gray J, Halpin J, Hopwood P, McKay J, Sheppard C, Sibbering M, Watson W, Wailoo A, Hutchinson. Clinical Guidelines and Evidence Review for The Classification and Care of Women at Risk of Familial Breast Cancer, NICE guideline CG014. London: National Collaborating Centre for Primary Care/University of Sheffield, 2004.
8. Huson SM, Compston DA, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 1989;26:704.
9. Stavrou T, Bromley CM, Nicholson HS, Byrne J, Packer RJ, Goldstein AM, Reaman GH. Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 2001;23:431.
10. Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, Katz L. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988;319:1033.
11. Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, Rajan B, Traish D. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 1992;304:1343.
12. Karlsson P, Holmberg E, Lundell M, Mattsson A, Holm LE, Wallgren A. Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat Res 1998;150:357.
13. Kantar M, Cetingul N, Kansoy S, Anacak Y, Demirtas E, Ersahin Y, Mutluer S. Radiotherapy-induced secondary cranial neoplasms in children. Childs Nerv Syst 2004;20:46.
14. Yousaf I, Byrnes DP, Choudhari KA. Meningiomas induced by high dose cranial irradiation. Br J Neurosurg 2003;17:219.
15. Salvati M, Frati A, Russo N, Caroli E, Polli FM, Minniti G, Delfini R. Radiation-induced gliomas: report of 10 cases and review of the literature. Surg Neurol 2003;60:60.
16. Amirjamshidi A, Abbassioun K. Radiation-induced tumors of the central nervous system occurring in childhood and adolescence. Four unusual lesions in three patients and a review of the literature. Childs Nerv Syst 2000;16:390.
17. Nishio S, Morioka T, Inamura T, Takeshita I, Fukui M, Sasaki M, Nakamura K, Wakisaka S. Radiation-induced brain tumours: potential late complications of radiation therapy for brain tumours. Acta Neurochir (Wien), 1998;140:763.
18. Sharif S, Ferner R, Birch J, R Gattamaneni, Gillespie J, Evans DGR. Second primary tumours in neurofibromatosis 1 (NF1) patients treated for optic glioma: substantial risks post radiotherapy. J Clin Oncol 2006;24:2570-5.
19. Ceccaroni M, Genuardi M, Legge F, Lucci-Cordisco E, Carrara S, D'Amico F, Greggi S, Scambia G. BRCA1-related malignancies in a family presenting with von Recklinghausen's disease. Gynecol Oncol 2002;86:375.
20. Schrock E, Badger P, Larson D, Erdos M, Wynshaw-Boris A, Ried T, Brody L. The murine homolog of the human breast and ovarian cancer susceptibility gene Brca1 maps to mouse chromosome 11D. Hum Genet 1996;97:256, .
21. Wilson CH, Griffith CD, Shrimankar J, Douglas F. Gynaecomastia, neurofibromatosis and breast cancer. Breast 2004;13:77.
22. Ogata H, Sato H, Takatsuka J, De Luca LM. Human breast cancer MDA-MB-231 cells fail to express the neurofibromin protein, lack its type I mRNA isoform and show accumulation of P-MAPK and activated Ras. Cancer Lett 2001;172:159.
23. Guran S, Safali M. A case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancer. Cancer Genet Cytogenet 2005;156:86.
24. Barbaric D, Stevens M, Dalla-Pozza L. Neurofibromatosis type 1 and multiple primary malignancies. Med Pediatr Oncol 2003;41:568.
25. Blatt J, Jaffe R, Deutsch M, Adkins JC. Neurofibromatosis and childhood tumors. Cancer 1986;57:1225.
26. Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuka J. Neurofibromatosis type 1 and childhood cancer. Cancer 1993;72:2746.
27. Friedman JM, Birch PH. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 1997;70:138.
28. Poyhonen M. A clinical assessment of neurofibromatosis type 1 (NF1) and segmental NF in Northern Finland. J Med Genet 2000;37:E43.
29. Korf BR. Malignancy in neurofibromatosis type 1. Oncologist 2000;5:477.
30. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002;39:311.
31. Evans DGR, Birch JM, Ramsden RT, Moffat D, Baser ME. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour-prone syndromes. J Med Genet 2006;43:289-94.
32. Rasmussen SA, Yang Q, Friedman JM. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 2001;68:1110.